miltefosine has been researched along with Mastocytosis in 1 studies
miltefosine: hexadecyl phosphocholine derivative of cisplatin; did not substantially activate HIV long terminal repeat; less toxic than cisplatin
miltefosine : A phospholipid that is the hexadecyl monoester of phosphocholine.
Mastocytosis: A rare neoplastic disorder characterized by a clonal proliferation of MAST CELLS, associated with KIT-D816 mutations, and accompanied by aberrant mast cell activation. The abnormal increase of MAST CELLS may occur in only the skin (MASTOCYTOSIS, CUTANEOUS), in extracutaneous tissues involving multiple organs (MASTOCYTOSIS, SYSTEMIC), or in solid tumors (MASTOCYTOMA).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Maurer, M | 1 |
| Magerl, M | 1 |
| Metz, M | 1 |
| Weller, K | 1 |
| Siebenhaar, F | 1 |
1 review available for miltefosine and Mastocytosis
| Article | Year |
|---|---|
Miltefosine: a novel treatment option for mast cell-mediated diseases.
Topics: Antineoplastic Agents; Dermatitis, Atopic; Humans; Mast Cells; Mastocytosis; Phosphorylcholine; Urti | 2013 |